Literature DB >> 25268728

Radiation therapy remains the key cost driver of oncology inpatient treatment.

Mihajlo Jakovljevic1, Ana Zugic, Ana Rankovic, Aleksandar Dagovic.   

Abstract

OBJECTIVE: Current radiation therapy capacities in Serbia and most of Eastern Europe are heavily lagging behind population needs. The primary study aim was assessment of direct costs of cancer medical care for patients suffering from cancer with assigned radiotherapy-based treatment protocols. Identification of key cost drivers and trends during 2010-2013 comparing brachytherapy and teleradiotherapy was a secondary objective of the study.
METHODS: Retrospective, bottom-up database analysis was conducted on electronic discharge invoices. Payer's perspective has been adopted with a 1-year long time horizon. Total sample size was 2544 patients during a 4-years long observation period (2010-2013). The sample consisted of all patients with confirmed malignancy disorder receiving inpatient radiation therapy in a large university hospital.
RESULTS: Diagnostics and treatment cost of cancer in the largest Western Balkans market of Serbia were heavily dominated by radiation therapy related direct medical costs. Total costs of care as well as mean cost per patient were steadily decreasing due to budget cuts caused by global recession. The paradox is that at the same time the budget share of radiotherapy increased for almost 15% and in value-based terms for €109 per patient (in total €109,330). Second ranked cost drivers were nursing care and imaging diagnostics. Costs of high-tech visualizing examinations were heavily dominated by nuclear medicine tests.
CONCLUSION: The budget impact of radiation oncology to the large tertiary care university clinics of the Balkans is likely to remain significant in the future. Brachytherapy exhibited a slow growth pattern, while teleradiotherapy remained stable in terms of value-based turnover of medical services. Upcoming heavy investment into the national network of radiotherapy facilities will emphasize the unsatisfied needs. Huge contemporary budget share of radiotherapy coupled with rising cancer prevalence brings this issue into the hot spot of the ongoing cost containment efforts by local governments.

Entities:  

Keywords:  Cancer; Costs; Hospital; Inpatient; Malignant tumor; Radiation therapy; Serbia; Treatment

Mesh:

Year:  2014        PMID: 25268728     DOI: 10.3111/13696998.2014.971162

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  13 in total

1.  Use of social media for the improvement of radiation safety knowledge among Saudi Arabian radiographers.

Authors:  Shayma-A Hijlis; Turki Alanzi; Fahad Alanezi; Hala Alhodaib; Arwa Althumairi; Afnan Aljaffary; Duaa Aljabri; Saja Alrayes; Demah Alsalman; Asma Al-Fayez; Sumaiah Alrawiai; Bashair AlThani; Zahraa Alakrawi; Amjad Saadah; Norah Alyousif
Journal:  Int Health       Date:  2022-05-02       Impact factor: 3.131

2.  Growing Burden of Non-Communicable Diseases in the Emerging Health Markets: The Case of BRICS.

Authors:  Mihajlo B Jakovljevic; Olivera Milovanovic
Journal:  Front Public Health       Date:  2015-04-23

3.  Commentary: Do health care workforce, population, and service provision significantly contribute to the total health expenditure? An econometric analysis of Serbia.

Authors:  Mihajlo Jakovljevic; Mirjana Varjacic
Journal:  Front Pharmacol       Date:  2017-02-06       Impact factor: 5.810

4.  Review of Diagnosis-Related Group-Based Financing of Hospital Care.

Authors:  Natasa Mihailovic; Sanja Kocic; Mihajlo Jakovljevic
Journal:  Health Serv Res Manag Epidemiol       Date:  2016-05-12

5.  Disability, Work Absenteeism, Sickness Benefits, and Cancer in Selected European OECD Countries-Forecasts to 2020.

Authors:  Mihajlo Jakovljevic; Christina Malmose-Stapelfeldt; Olivera Milovanovic; Nemanja Rancic; Dubravko Bokonjic
Journal:  Front Public Health       Date:  2017-02-27

6.  Cost-effectiveness of colorectal cancer screening in Ukraine.

Authors:  Nelya Melnitchouk; Djøra I Soeteman; Jennifer S Davids; Adam Fields; Joshua Cohen; Farzad Noubary; Andrey Lukashenko; Olena O Kolesnik; Karen M Freund
Journal:  Cost Eff Resour Alloc       Date:  2018-06-07

7.  Improvements in Neonatal and Childhood Medical Care - Perspective from the Balkans.

Authors:  Vesna Velickovic; Aleksandra Simovic; Gordana Lazarevic; Marija Lazarevic; Mihajlo Jakovljevic
Journal:  Front Public Health       Date:  2015-08-27

8.  The New and Old Europe: East-West Split in Pharmaceutical Spending.

Authors:  Mihajlo Jakovljevic; Marija Lazarevic; Olivera Milovanovic; Tatjana Kanjevac
Journal:  Front Pharmacol       Date:  2016-02-09       Impact factor: 5.810

9.  Modeling Determinants of Health Expenditures in Malaysia: Evidence from Time Series Analysis.

Authors:  Habib N Khan; Radzuan B Razali; Afza B Shafie
Journal:  Front Pharmacol       Date:  2016-03-30       Impact factor: 5.810

10.  Trends and Patterns of Disparities in Oral Cavity and Pharyngeal Cancer in Serbia: Prevalence and Economic Consequences in a Transitional Country.

Authors:  Gordana Djordjevic; Aleksandar Dagovic; Vladimir Ristic; Tatjana Kanjevac; Denis Brajkovic; Milica Popovic
Journal:  Front Pharmacol       Date:  2017-06-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.